Specifically, aberrant expression of markers such as CD30 and CD15, an incomplete, deficient B-cell phenotype and EBV-association may result in a challenging differential diagnosis with classic Hodgkin lymphoma (CHL), especially lymphocyte-rich classic Hodgkin lymphoma (LRCHL). The gene discussed is FUT4; the disease is classic Hodgkin lymphoma.